CA Stock MarketDetailed Quotes
APC Advanced Proteome Therapeutics Corp
- 0.020
- 0.0000.00%
15min DelayMarket Closed May 16 16:00 ET
822.54KMarket Cap-377P/E (TTM)
0.000High0.000Low0Volume0.000Open0.020Pre Close0.00Turnover0.02052wk High0.00%Turnover Ratio41.13MShares0.02052wk Low-0.053EPS TTM738.91KFloat Cap66.000Historical High1.54P/E (Static)36.95MShs Float0.010Historical Low0.013EPS LYR0.00%Amplitude--Dividend TTM1.67P/B1Lot Size--Div YieldTTM
Advanced Proteome Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | (Q3)Apr 30, 2022 | (Q2)Jan 31, 2022 | (Q1)Oct 31, 2021 | (FY)Jul 31, 2021 | (Q4)Jul 31, 2021 | (Q3)Apr 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 8.70%286.69K | 26.81%256.33K | 42.41%959.83K | 50.03%257.8K | 22.72%236.16K | 40.55%263.74K | 65.62%202.13K | 18.25%673.97K | 0.26%171.83K | 39.82%192.43K |
| Selling and administrative expenses | 58.40%119.42K | 155.84%80.64K | -3.77%272K | -95.87%-426.55K | 22.48%235K | -59.70%75.39K | -74.05%31.52K | -50.12%282.66K | -227.66%-217.77K | 40.23%191.86K |
| -General and administrative expense | 58.40%119.42K | 155.84%80.64K | -3.77%272K | -95.87%-426.55K | 22.48%235K | -59.70%75.39K | -74.05%31.52K | -50.12%282.66K | -227.66%-217.77K | 40.23%191.86K |
| Research and development costs | -11.22%167.15K | 2.99%175.63K | 75.97%687.5K | ---- | ---- | --188.27K | --170.52K | --390.68K | ---- | ---- |
| Depreciation amortization depletion | 52.44%125 | -30.49%57 | -47.60%328 | -192.48%-3.15K | 104.05%1.16K | -85.56%82 | -85.54%82 | -80.70%626 | -232.80%-1.08K | -29.96%568 |
| -Depreciation and amortization | 52.44%125 | -30.49%57 | -47.60%328 | -192.48%-3.15K | 104.05%1.16K | -85.56%82 | -85.54%82 | -80.70%626 | -232.80%-1.08K | -29.96%568 |
| Operating profit | -8.70%-286.69K | -26.81%-256.33K | -42.41%-959.83K | -50.03%-257.8K | -22.72%-236.16K | -40.55%-263.74K | -65.62%-202.13K | -18.25%-673.97K | -0.26%-171.83K | -39.82%-192.43K |
| Net non-operating interest income (expenses) | -78.12%-11.99K | -80.34%-12.34K | 0.38%-26.64K | 5.41%-6.59K | 2.76%-6.47K | 0.81%-6.73K | -8.09%-6.84K | 9.45%-26.74K | -288.89%-6.97K | 64.88%-6.66K |
| Non-operating interest income | --0 | -8.06%570 | 269.07%2.46K | -1.05%659 | --573 | --607 | --620 | --666 | --666 | --0 |
| Non-operating interest expense | 63.39%11.99K | 72.99%12.91K | 6.17%29.1K | -5.03%7.25K | 5.85%7.04K | 8.13%7.34K | 17.89%7.46K | -7.20%27.41K | 306.94%7.64K | -64.88%6.66K |
| Other net income (expenses) | -103.99%-34.11K | -98.81%10.14K | 229.88%1.58M | -53.13%147.19K | 82.18%-266.65K | 330.30%854.56K | 459.27%848.74K | -2,203.63%-1.22M | 632.07%314.02K | -10,263.44%-1.5M |
| Gain on sale of security | -103.99%-34.11K | -98.81%10.14K | 228.07%1.58M | -42.60%147.19K | 81.68%-266.65K | 330.30%854.56K | 459.27%848.74K | -1,908.39%-1.24M | 627.56%256.42K | -9,988.69%-1.46M |
| Special income (charges) | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 264.78%17.16K | 653.10%57.6K | ---40.44K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 288.32%40.44K | --0 | --40.44K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---57.6K | ---- | ---- |
| Income before tax | -156.98%-332.79K | -140.41%-258.52K | 131.11%597.48K | -186.68%-117.2K | 69.95%-509.28K | 13,960.81%584.09K | 275.47%639.78K | -254.63%-1.92M | 159.64%135.22K | -1,094.84%-1.7M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -156.98%-332.79K | -140.41%-258.52K | 131.11%597.48K | -186.68%-117.2K | 69.96%-509.18K | 13,960.81%584.09K | 275.47%639.78K | -254.63%-1.92M | 159.64%135.22K | -1,094.86%-1.7M |
| Net income continuous operations | -156.98%-332.79K | -140.41%-258.52K | 131.11%597.48K | -186.68%-117.2K | 69.95%-509.28K | 13,960.81%584.09K | 275.47%639.78K | -254.63%-1.92M | 159.64%135.22K | -1,094.84%-1.7M |
| Noncontrolling interests | -25.45%-54.81K | -35.31%-48.81K | -89.12%-162.13K | -163.28%-41.05K | -69.56%-41.33K | -86.80%-43.69K | -61.19%-36.07K | 5.65%-85.73K | 43.47%-15.59K | -10.71%-24.37K |
| Net income attributable to the company | -144.28%-277.99K | -131.03%-209.71K | 141.41%759.62K | -150.50%-76.16K | 72.00%-467.85K | 2,179.42%627.77K | 297.48%675.85K | -307.10%-1.83M | 175.73%150.81K | -1,294.02%-1.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -144.28%-277.99K | -131.03%-209.71K | 141.41%759.62K | -150.50%-76.16K | 72.00%-467.85K | 2,179.42%627.77K | 297.48%675.85K | -307.10%-1.83M | 175.73%150.81K | -1,294.02%-1.67M |
| Diluted earnings per share | -150.00%-0.01 | -150.00%-0.01 | 116.67%0.01 | -200.00%-0.01 | 80.00%-0.01 | 1,974.69%0.02 | 300.00%0.02 | -200.00%-0.06 | 200.00%0.01 | -776.12%-0.05 |
| Basic earnings per share | -150.00%-0.01 | -150.00%-0.01 | 116.67%0.01 | -200.00%-0.01 | 80.00%-0.01 | 1,974.69%0.02 | 300.00%0.02 | -200.00%-0.06 | 200.00%0.01 | -776.12%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg